AVTX
Avalo Therapeutics Inc
15.00$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -1,263.9% | 45.0% | -17.1% | -283.5% | -605.2% | -1,313.3% | -148.2% | -1,594.6% | -11,123.8% | -87,216.9% | |
| – | – | 2.3% | 1.5% | 24.9% | 57.5% | 27.5% | 30.7% | 0.9% | 8.2% | 38.3% | 583.1% | |
| – | – | 147.0% | 4.2% | 13.3% | 37.5% | 101.3% | 151.4% | 41.8% | 180.7% | 1,327.0% | 23,086.4% | |
| – | – | – | 1.8% | 143.8% | -36.9% | 381.5% | 151.8% | – | – | – | – | |
| – | – | 7.6% | -1.7% | 47.7% | -30.0% | -66.2% | 52.6% | 26.4% | -480.2% | -1,067.6% | 6,510.2% | |
| – | – | 3.0% | 0.1% | 3.1% | 3.9% | 0.9% | 2.1% | 0.5% | 8.2% | 0.0% | 0.0% | |
| – | – | -3.0% | -68.0% | 4.7% | -6.6% | 166.2% | -2.1% | -0.5% | -6.9% | 80.7% | -138,508.5% | |
| – | – | – | – | – | 16.0% | – | 609.5% | 82.0% | – | – | – | |
| – | – | – | – | – | -0.5% | -1.4% | 6.8% | 0.4% | 3.5% | 15.4% | 39.0% | |
| – | – | – | -8.5% | -1.4% | -3.8% | 491.1% | 609.5% | -82.0% | -1,104.2% | 0.0% | – | |
| – | – | -123.7% | 13.4% | 56.8% | 186.1% | 668.5% | 1,977.8% | -81.4% | 1,301.6% | 39,875.1% | 24,723.7% | |
| – | – | -1,390.6% | -9.5% | 44.4% | -104.0% | 229.5% | 662.4% | -230.2% | -299.9% | 28,832.0% | -201,001.7% | |
| – | – | -1,267.0% | 44.9% | -20.1% | -287.3% | -606.1% | -1,315.4% | -148.7% | -1,602.8% | -11,123.8% | -87,216.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.